Fiche publication


Date publication

janvier 2019

Journal

The oncologist

Auteurs

Membres identifiés du Cancéropôle Est :
Pr KURTZ Jean-Emmanuel , Pr MALOUF Gabriel


Tous les auteurs :
Malouf GG, Beinse G, Adam J, Mir O, Chamseddine AN, Terrier P, Honore C, Spano JP, Italiano A, Kurtz JE, Coindre JM, Blay JY, Le Cesne A

Résumé

Alveolar soft part sarcoma (ASPS) is a rare sarcoma characterized by a slow evolution, brain metastasis (BM), and resistance to doxorubicin. Antiangiogenic therapies (AAT) have shown clinical activity, but little is known about the optimal therapeutic strategy, specifically considering BM.

Mots clés

Alveolar soft part sarcoma, Angiogenesis inhibitors, Neoplasm drug resistance, Neoplasm metastasis

Référence

Oncologist. 2019 Jan 9;: